ODDB.org: Open Drug Database

Swissmedic Registration	68454	Date of registration	13.06.2022
Company name	AstraZeneca AG	Revision date
		Valid until	12.06.2027
Indication		Date of market entry
Index Therapeuticus (BSV)	03.04.50.	Revocation Date
Index Therapeuticus (Swissmedic)	03.04.50.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Tezspire	Injektionslösung in einer Fertigspritze	Injection solution in prefilled syringe (Tezepelumabum 210 mg)	R03DX11	CI

2025	©ywesee GmbH